Hints and tips:
...Tokat, 46, joined Centerview in 2009 with a group from Merrill Lynch that specialised in pharmaceutical and biotech companies....
...Greater user choice may sound fine in theory, they argue, but it will challenge fundamental aspects of how services work....
...Many are medtech or biotech companies, including Decibel Therapeutics and Fulcrum Therapeutics. Google dissolved healthcare unit Google Health in 2021....
...Vanguard also voted against a proposal at uniQure, a Dutch biotech company, to give the board permission to issue shares and options....
...“If you’re a garden-variety biotech start-up with little revenue, the auditing isn’t that complicated,” said Jay Ritter, an IPO expert at the University of Florida....
...And one smart listen: Gene sequencing company Illumina took a bet on cancer detection start-up Grail during the height of the biotech boom. The FT’s Behind the Money podcast explains what went wrong....
...On Monday it charged media and entertainment company Impact Theory LLC with conducting an unregistered offering of crypto asset securities in the form of non-fungible tokens....
...PwC and KPMG have been investigated in Hong Kong for auditing work on two Chinese companies — indebted property group Evergrande and US-listed biotech China Medical Technologies, respectively....
...Just a few years later, the financial crisis eliminated several prominent full-service investment banks including Bear Stearns, Lehman Brothers and Merrill Lynch....
...His start-up Inceptive is a biotech company that is designing “biological software” using deep learning techniques....
...Big companies started rethinking the risks of relationships with massive financial institutions peddling credit lines, interest-rate swaps and other services alongside sensitive M&A advice....
...It basically looks like a massive near-$28bn bet on a grimy future where sanitation will be the in-demand service. Mad Max, but with even more garbage....
...Finback was considering buying a stake in Gideon Cyber Systems LLC, according to the term sheet....
...Its website says it will help clients “Manage Your Balance Sheet More Effectively”, a service we’re assuming FTX didn’t take advantage of....
...In addition to Didi, people close to Boyu said it had invested in seven or eight companies that successfully launched IPOs last year, including Cloud Village, the music streaming unit of NetEase, and biotech...
...While OneWeb and Elon Musk’s Starlink battle in space to bring broadband to the masses, Facebook and Google are going into the deep to bolster the internet backbone that delivers their services to business...
...Wise also pointed to Ortho Clinical Diagnostics, which Carlyle spun out of US drugmaker Johnson & Johnson in 2014....
...The hedge fund also won over the influential advisory firms Glass Lewis and Institutional Shareholder Services and top shareholders including Calstrs, the second-largest US retirement fund, and BlackRock...
...Following in the footsteps of Washington Post owner Jeff Bezos and biotech billionaire Patrick Soon-Shiong’s purchase of the LA Times, Maryland hotel magnate Stewart Bainum has agreed to launch a non-profit...
...IPOs: optimistic prognosis (Lex) EU cannot be ‘captured’ by City of London, warns financial services chief (FT) Continental rules out deeper job cuts over electric car shake-up (FT) Japanese retail investors...
...to clinch deal (FT) Former Guggenheim Partners president made bid for Premier League’s Chelsea (WSJ) IFF vies with Kerry in deal for DuPont nutrition business (BBG) Sanofi agrees $2.5bn deal for US biotech...
...A new battleground has emerged: biotech....
...The report claims that one of Mr Barnett’s funds provided financial support that helped US biotech firm Napo Pharmaceuticals repay money it owed Burford from litigation....
...Further off, Alphabet’s so-called “other bets” — which include biotech, broadband networks and driverless cars — offer the chance of growth in entirely new markets....
...His fund, Sarissa, focuses on targets in the biotech and pharmaceutical markets. Mr Koffey, 40, joined DE Shaw in May last year to help build the $45bn hedge fund’s activist practice....
International Edition